Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-22

Clinical Trial Update: A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety [Phase 3]

View source ↗

Summary

Phase III study completed evaluating the efficacy and safety of insulin aspart injection for diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin aspart injection (insulin aspart)

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Diabetes | Phase 3 | Status: COMPLETED